Keryx Biopharms Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for KERYX BIOPHARMS, and what generic alternatives to KERYX BIOPHARMS drugs are available?
KERYX BIOPHARMS has one approved drug.
There are fifteen US patents protecting KERYX BIOPHARMS drugs.
There are one hundred and thirty-one patent family members on KERYX BIOPHARMS drugs in twenty-six countries.
Summary for Keryx Biopharms
International Patents: | 131 |
US Patents: | 15 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Keryx Biopharms
Expired US Patents for Keryx Biopharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | 5,753,706 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Keryx Biopharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 2456426 | ⤷ Try a Trial |
Australia | 2006279333 | ⤷ Try a Trial |
Hong Kong | 1205129 | ⤷ Try a Trial |
Japan | 6632842 | ⤷ Try a Trial |
Hungary | E025264 | ⤷ Try a Trial |
China | 100386336 | ⤷ Try a Trial |
Japan | 2014240405 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.